Physician profile
Wei Chu
NPI 1073747739
$636.65
in general payments reported to CMS, 2019-2025
15 companies · $58.74 in 2025
The $58.74 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.40 · 2021: $29.07 · 2022: $144 · 2023: $170 · 2024: $149 · 2025: $58.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $204.14 | 2022-2024 | Slynd |
| Organon LLC | $138.18 | 2021-2025 | Nexplanon, Nuvaring |
| Bayer Healthcare Pharmaceuticals INC. | $64.82 | 2019-2023 | |
| Hologic Sales and Service, LLC | $33.82 | 2025 | Aptima |
| Scynexis, INC. | $31.48 | 2022 | |
| Pfizer INC. | $28.90 | 2023-2024 | |
| Roche Diagnostics Corporation | $18.96 | 2019 | |
| Mylan Pharmaceuticals INC. | $17.41 | 2022 | |
| Daiichi Sankyo INC. | $14.99 | 2022 | |
| Merck Sharp & Dohme LLC | $14.85 | 2021 | |
| Evofem Biosciences, INC. | $14.75 | 2022 | |
| Myovant Sciences INC. | $14.38 | 2022 | |
| Glaxosmithkline, LLC. | $14.10 | 2019 | |
| Coopersurgical, INC. | $13.00 | 2019 | |
| Hikma Pharmaceuticals USA | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.